Literatur
- 1
Castle W, Fuller R, Hall J, Palmer J.
Serevent nationwide surveillance study:
comparison of salmeterol with salbutamol in asthmatic patients who
require regular bronchodilator treatment.
BMJ.
1993;
306
1034-1037
- 2
Cooper P R, Panettieri Jr R A.
Steroids
completely reverse albuterol-induced beta(2)-adrenergic receptor
tolerance in human small airways.
J Allergy Clin Immunol.
2008;
122
734-740
- 3
Hasford J, Virchow J C.
Excess mortality
in patients with asthma on long-acting beta2-agonists.
Eur
Respir J.
2006;
28
900-902
- 4
Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod F B, Bousquet J.
Lung function and asthma
control with beclomethasone and formoterol in a single inhaler.
Respir Med.
2008;
103
41-49
- 5
Inman W H, Adelstein A M.
Asthma mortality
and pressurised aerosols.
Lancet.
1969;
2
693
- 6
Mcivor R A, Pizzichini E, Turner M O, Hussack P, Hargreave F E, Sears M R.
Potential masking
effects of salmeterol on airway inflammation in asthma.
Am
J Respir Crit Care Med.
1998;
158
924-930
- 7
Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C.
Noncompliance and treatment
failure in children with asthma.
J Allergy Clin Immunol.
1996;
98
1051-1057
- 8
Nelson H S, Weiss S T, Bleecker E R, Yancey S W, Dorinsky P M. SMART Study Group .
The
Salmeterol Multicenter Asthma Research Trial: a comparison of usual
pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
Chest.
2006;
129
15-26
- 9
Papi A, Paggiaro P L, Nicolini G, Vignola A M, Fabbri L M. Inhaled Combination Asthma
Treatment versus
SYmbicort (ICAT SY) Study Group .
Beclomethasone/formoterol
versus budesonide/formoterol combination therapy in asthma.
Eur Respir J.
2007;
29
682-689
- 10 Ratner B.
. In: Abramson HA, ed Treatment of Asthma. London; Baillière, Tindall & Cox, Ltd 1952:
xiv, 752
- 11
Salpeter S R, Ormiston T M, Salpeter E E.
Meta-analysis: respiratory tolerance
to regular beta2-agonist use in patients with asthma.
Ann
Intern Med.
2004;
140
802-813
- 12
Sears M R, Taylor D R, Print C G. et al .
Regular inhaled beta-agonist treatment
in bronchial asthma.
Lancet.
1990;
336
1391-1396
- 13
Thongngarm T, Silkoff P E, Kossack W S, Nelson H S.
Hydrofluoroalkane-134A
beclomethasone or chlorofluorocarbon fluticasone: effect on small
airways in poorly controlled asthma.
J Asthma.
2005;
42
257-263
- 14
Wolfe J, Laforce C, Friedman B. et al .
Formoterol, 24 microg bid, and serious
asthma exacerbations: similar rates compared with formoterol, 12
microg bid, with and without extra doses taken on demand, and placebo.
Chest.
2006;
129
27-38
Prof. Dr. Christian Virchow
Klinik und Poliklinik für Innere Medizin,
Abteilung für Pneumologie, Medizinische
Fakultät der Universität Rostock
Ernst-Heydemann-Straße
6
Phone: 0381/4947-460
Fax: 0381/4947-392
Email: j.c.virchow@med.uni-rostock.de
